Project Details
Description
An open-label, dose-escalating study of the pharmacokinetics, safety and tolerability of fesoterodine in pediatric overactive bladder patients aged 11-17 years
| Status | Finished |
|---|---|
| Effective start/end date | 2/18/09 → 12/31/10 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.